Rigel Pharmaceuticals Inc (NASDAQ: RIGL) stock closed at $20.56 on 12/10/24 after a major decline of -11.2%. Moreover, this decline was accompanied by exceptionally high trading volume at 282% of normal. The stock has declined -24.0% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Rigel Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment